PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
907.47%
Some net income increase while CRK is negative at -200.26%. John Neff would see a short-term edge over the struggling competitor.
19.00%
Some D&A expansion while CRK is negative at -16.86%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
63.96%
Some yoy growth while CRK is negative at -133.90%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-123.68%
Negative yoy SBC while CRK is 4.06%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
30.25%
Less working capital growth vs. CRK's 977.83%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.25%
Lower 'other working capital' growth vs. CRK's 72.26%. David Dodd would see fewer unexpected short-term demands on cash.
-196.00%
Negative yoy while CRK is 157.67%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.26%
Negative yoy CFO while CRK is 12.91%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-6.79%
Both yoy lines negative, with CRK at -12.11%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
740.95%
Acquisition growth of 740.95% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
1064.52%
Purchases growth of 1064.52% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-79.82%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
37.16%
Growth of 37.16% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
355.54%
We have mild expansions while CRK is negative at -12.11%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
92.80%
Debt repayment similar to CRK's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.